A detailed history of Engineers Gate Manager LP transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 22,813 shares of CCCC stock, worth $98,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,813
Holding current value
$98,324
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.43 - $7.38 $101,061 - $168,359
22,813 New
22,813 $130,000
Q1 2024

May 15, 2024

BUY
$5.3 - $11.0 $553,145 - $1.15 Million
104,367 New
104,367 $852,000
Q2 2023

Aug 14, 2023

BUY
$2.75 - $3.77 $29,975 - $41,093
10,900 New
10,900 $29,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $211M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.